🇺🇸 FDA
Patent

US 11564945

Chimeric antigen receptor and use thereof

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 11564945 (Chimeric antigen receptor and use thereof) held by Nanjing Legend Biotech Co., Ltd expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nanjing Legend Biotech Co., Ltd
Grant date
Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/48, A61K35/28